GB2346971B - Blood test for infectious prion protein using antibodies raised to eye lens crystallin proteins - Google Patents

Blood test for infectious prion protein using antibodies raised to eye lens crystallin proteins

Info

Publication number
GB2346971B
GB2346971B GB9903764A GB9903764A GB2346971B GB 2346971 B GB2346971 B GB 2346971B GB 9903764 A GB9903764 A GB 9903764A GB 9903764 A GB9903764 A GB 9903764A GB 2346971 B GB2346971 B GB 2346971B
Authority
GB
United Kingdom
Prior art keywords
eye lens
blood test
prion protein
antibodies raised
infectious prion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB9903764A
Other versions
GB2346971A (en
GB9903764D0 (en
Inventor
Audrey Ann Coop
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to GB9903764A priority Critical patent/GB2346971B/en
Publication of GB9903764D0 publication Critical patent/GB9903764D0/en
Publication of GB2346971A publication Critical patent/GB2346971A/en
Application granted granted Critical
Publication of GB2346971B publication Critical patent/GB2346971B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2828—Prion diseases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
GB9903764A 1999-02-19 1999-02-19 Blood test for infectious prion protein using antibodies raised to eye lens crystallin proteins Expired - Fee Related GB2346971B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB9903764A GB2346971B (en) 1999-02-19 1999-02-19 Blood test for infectious prion protein using antibodies raised to eye lens crystallin proteins

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9903764A GB2346971B (en) 1999-02-19 1999-02-19 Blood test for infectious prion protein using antibodies raised to eye lens crystallin proteins

Publications (3)

Publication Number Publication Date
GB9903764D0 GB9903764D0 (en) 1999-04-14
GB2346971A GB2346971A (en) 2000-08-23
GB2346971B true GB2346971B (en) 2004-07-21

Family

ID=10848054

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9903764A Expired - Fee Related GB2346971B (en) 1999-02-19 1999-02-19 Blood test for infectious prion protein using antibodies raised to eye lens crystallin proteins

Country Status (1)

Country Link
GB (1) GB2346971B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1437144A1 (en) * 2003-01-09 2004-07-14 IVPT Gmbh Rapid in-vivo test for Transmissible Spongiform Encephalopathy in the eye

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US646295A (en) * 1899-05-18 1900-03-27 Alex W R Maas Folding fowl-coop.
EP0074770A1 (en) * 1981-09-04 1983-03-23 Kabushiki Kaisha Yakult Honsha Camptothecin-1-oxide derivatives, process for preparing same, formulations comprising said derivatives and said derivatives for use in producing an anti-tumour effect
EP0444856A2 (en) * 1990-02-26 1991-09-04 Albert Einstein College Of Medicine Of Yeshiva University Diagnostic assay for Alzheimer's disease
WO1993023432A1 (en) * 1992-05-15 1993-11-25 New York University Soluble prion polypeptides, and methods for detecting and purifying thereof
WO1997010505A1 (en) * 1995-09-14 1997-03-20 The Regents Of The University Of California ANTIBODIES SPECIFIC FOR NATIVE PrP?Sc¿
WO1998031824A1 (en) * 1997-01-21 1998-07-23 Macquarie Research Ltd. Fluorescent dyes from microorganisms
EP0861900A1 (en) * 1997-02-21 1998-09-02 Erziehungsdirektion Of The Canton Zurich Immunological detection of prions

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US646295A (en) * 1899-05-18 1900-03-27 Alex W R Maas Folding fowl-coop.
EP0074770A1 (en) * 1981-09-04 1983-03-23 Kabushiki Kaisha Yakult Honsha Camptothecin-1-oxide derivatives, process for preparing same, formulations comprising said derivatives and said derivatives for use in producing an anti-tumour effect
EP0444856A2 (en) * 1990-02-26 1991-09-04 Albert Einstein College Of Medicine Of Yeshiva University Diagnostic assay for Alzheimer's disease
WO1993023432A1 (en) * 1992-05-15 1993-11-25 New York University Soluble prion polypeptides, and methods for detecting and purifying thereof
WO1997010505A1 (en) * 1995-09-14 1997-03-20 The Regents Of The University Of California ANTIBODIES SPECIFIC FOR NATIVE PrP?Sc¿
WO1998031824A1 (en) * 1997-01-21 1998-07-23 Macquarie Research Ltd. Fluorescent dyes from microorganisms
EP0861900A1 (en) * 1997-02-21 1998-09-02 Erziehungsdirektion Of The Canton Zurich Immunological detection of prions

Also Published As

Publication number Publication date
GB2346971A (en) 2000-08-23
GB9903764D0 (en) 1999-04-14

Similar Documents

Publication Publication Date Title
DE69703813T2 (en) SYSTEM FOR EXPRESSING HETEROLOGICAL ANTIGENS AS FUSION PROTEINS
EP1490094A4 (en) Antibody fusion proteins: effective adjuvants of protein vaccination
NO20016243D0 (en) Anti-alpha-beta3 recombinant human antibodies, nucleic acids encoding the same, and methods of recycling
NO980915L (en) Recombinant anti-CD4 antibody suitable for human therapy
DK0699687T3 (en) Process for purifying recombinant human serum albumin
DK2236152T3 (en) Albumin Fusion Proteins
PL362324A1 (en) Artificial fusion proteins with reduced immunogenicity
NO995712D0 (en) Ophthalmic preparations
DE69840283D1 (en) Device for eye examination
NO980566D0 (en) Allergen-XCD32 fusion proteins
GB9913437D0 (en) Fusion proteins
NO20021275D0 (en) Transgent produced fusion proteins
AU3916400A (en) Human transmembrane proteins
GB2346971B (en) Blood test for infectious prion protein using antibodies raised to eye lens crystallin proteins
WO2001094949A3 (en) Soluble cd1 compositions and uses thereof
AU2001291050A1 (en) Viral chemokine-tumur antigen fusion proteins
AU2003298827A8 (en) Methods for preparing antigen masked red blood cells having reduced hemolysis by sera
AU2001286303A1 (en) Recombinant fusion protein for diagnosis of tsutsugamushi disease
AU2452301A (en) Protein methylarginine-specific antibodies
AU2003226907A8 (en) Method for the preparation of recombinant mammalian heparin-binding protein (hbp)
AU1216988A (en) Immunogenic fusion proteins which contain Epstein-Barr virus protein
DK1171470T3 (en) Placenta protein antibodies 13
NO20021244L (en) Subunit-optimized fusion proteins
AU2001245815A1 (en) Human immune response proteins
KR970702731A (en) A novel brain endothelial cell protein and methods for its use

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20140219